You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Cefdinir - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for cefdinir and what is the scope of patent protection?

Cefdinir is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Anda Repository, Aurobindo Pharma, Lupin, Sandoz, Teva Pharms, and Abbvie, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for cefdinir. Twenty-four suppliers are listed for this compound.

Summary for cefdinir

US Patents:	0
Tradenames:	2
Applicants:	7
NDAs:	14
Drug Master File Entries:	12
Finished Product Suppliers / Packagers:	24
Raw Ingredient (Bulk) Api Vendors:	68
Clinical Trials:	27
Patent Applications:	7,500
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for cefdinir
Drug Sales Revenues:	Drug sales revenues for cefdinir
What excipients (inactive ingredients) are in cefdinir?	cefdinir excipients list
DailyMed Link:	cefdinir at DailyMed

See drug prices for cefdinir

See drug sales revenues for cefdinir

Recent Clinical Trials for cefdinir

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Assistance Publique - Hôpitaux de Paris	Phase 4
Mercy Health Ohio	Phase 2
Northeast Ohio Medical University	Phase 2

See all cefdinir clinical trials

Pharmacology for cefdinir

Drug Class	Cephalosporin Antibacterial

Anatomical Therapeutic Chemical (ATC) Classes for cefdinir

J01DD	Third-generation cephalosporins
J01D	OTHER BETA-LACTAM ANTIBACTERIALS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for cefdinir

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Anda Repository	CEFDINIR	cefdinir	FOR SUSPENSION;ORAL	065429-002	Jul 18, 2007	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Sandoz	CEFDINIR	cefdinir	CAPSULE;ORAL	065330-001	Apr 6, 2007	AB	RX	No	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Aurobindo Pharma	CEFDINIR	cefdinir	FOR SUSPENSION;ORAL	065473-001	Dec 14, 2007	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for cefdinir

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	OMNICEF	cefdinir	FOR SUSPENSION;ORAL	050749-002	Jul 29, 2004	⤷ Try a Trial	⤷ Try a Trial
Abbvie	OMNICEF	cefdinir	CAPSULE;ORAL	050739-001	Dec 4, 1997	⤷ Try a Trial	⤷ Try a Trial
Abbvie	OMNICEF	cefdinir	FOR SUSPENSION;ORAL	050749-001	Dec 4, 1997	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.